Form 4: Quest Diagnostics Director Timothy Ring Increases Phantom Stock Holdings
Insider Transaction Report
Quest Diagnostics Director Timothy M. Ring acquired 236 phantom stock units through elective deferrals of cash compensation, increasing his total holdings to 16,725.378 units.
Summary
- Timothy M. Ring, a Director of Quest Diagnostics Inc. (DGX), acquired 236 phantom stock units (PSUs) on July 1, 2025.
- The PSUs were acquired at a price of $0, as they represent elective deferrals of his cash compensation under the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors.
- Following this transaction, Mr. Ring beneficially owns a total of 16,725.378 phantom stock units.
- These phantom stock units are payable in cash upon Mr. Ring's termination of service as a director.
- The total reported phantom stock units include those credited from dividend reinvestment transactions, which are exempt from reporting pursuant to Rule 16a-11.
Sentiment
Score: 7
Explanation: The acquisition of phantom stock units by a director, through elective deferrals of cash compensation, generally indicates alignment of interests with shareholders and confidence in the company's long-term performance. This is a routine insider transaction disclosure and is mildly positive.
Positives
- Director Timothy M. Ring's acquisition of phantom stock units through elective deferrals demonstrates a continued alignment of his interests with those of the company's shareholders.
- The increase in phantom stock unit holdings indicates a commitment to the company's long-term performance and stability.
Future Outlook
This Form 4 filing reports a specific insider transaction and does not contain any forward-looking statements or guidance regarding the company's future performance or strategic outlook.
Industry Context
This filing details a routine insider transaction related to director compensation, which is a common practice across various industries to align management and board interests with shareholder value. It does not provide broader industry trends or competitive analysis.
Related Party Transactions
- The acquisition of phantom stock units by Director Timothy M. Ring is a related party transaction, as it involves compensation from Quest Diagnostics Incorporated to a member of its board of directors under a deferred compensation plan.
Stakeholder Impact
- Shareholders: The transaction indicates increased alignment of Director Timothy M. Ring's financial interests with those of the shareholders, as his compensation is tied to the company's equity performance through phantom stock units.
Next Steps
- The phantom stock units will become payable in cash upon Timothy M. Ring's termination of service as a director.
Key Dates
| Date | Description |
|---|---|
| 07/01/2025 | Date of earliest transaction for the acquisition of phantom stock units by Timothy M. Ring. |
| 07/02/2025 | Date the Form 4 was signed by Sean D. Mersten, Attorney in Fact for Timothy M. Ring. |
Keywords
Quest Diagnostics, DGX, Timothy M. Ring, Form 4, Insider Transaction, Phantom Stock Units, Director Compensation, SEC Filing, Deferred Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.